Does rosiglitazone adversely affect bone formation and bone mineral density in postmenopausal women?
Nat Clin Pract Endocrinol Metab
.
2007 Sep;3(9):622-3.
doi: 10.1038/ncpendmet0562.
Epub 2007 Jun 26.
Authors
Ann V Schwartz
1
,
Steven R Cummings
Affiliation
1
Department of Epidemiology and Biostatistics, University of California San Francisco, 185 Berry Street, Suite 5700, San Francisco, CA 94107, USA. aschwartz@psg.ucsf.edu
PMID:
17593915
DOI:
10.1038/ncpendmet0562
No abstract available
Publication types
Comment